Goldman Sachs Maintains Buy on Legence, Raises Price Target to $52
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $46 to $52.
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $46 to $52.